{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:11:04Z","timestamp":1769065864362,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaip.2014.09.009","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T07:01:46Z","timestamp":1415257306000},"page":"653-657.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Aspirin or Other Nonsteroidal Inflammatory Agent Exacerbated Asthma"],"prefix":"10.1016","volume":"2","author":[{"given":"Dennis K.","family":"Ledford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally E.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.09.009_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-66-3-568","article-title":"Bronchial asthma induced by indomethacin","volume":"66","author":"Vanselow","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2222.2002.01333.x","article-title":"The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors","volume":"32","author":"Szczeklik","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.09.009_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2500\/aap.2012.33.3541","article-title":"Aspirin-exacerbated respiratory disease: burden of disease","volume":"33","author":"Chang","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2014.09.009_bib4","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"Natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gemimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2014.09.009_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2014.09.009_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1034\/j.1398-9995.2003.00267.x","article-title":"Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland","volume":"58","author":"Kasper","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.09.009_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2014.09.009_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0091-6749(76)90059-2","article-title":"Refractory period to aspirin in a patient with aspirin-induced asthma","volume":"57","author":"Zeiss","year":"1976","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult to treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ACI.0000000000000021","article-title":"An update on the pathogenesis of the upper airway in aspirin-exacerbated respiratory disease","volume":"14","author":"Choi","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","article-title":"Association of serum periostin with aspirin- exacerbated respiratory disease","volume":"113","author":"Kim","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-78-1-57","article-title":"Familial occurrence of asthma, nasal polyps, and aspirin intolerance","volume":"78","author":"Lockey","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4168\/aair.2013.5.5.258","article-title":"Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways","volume":"5","author":"Park","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2014.09.009_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FPC.0b013e328361d4bb","article-title":"Association analysis of tapasin polymorphisms with aspirin-exacerbated respiratory disease in asthmatics","volume":"23","author":"Cho","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2014.09.009_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4168\/aair.2014.6.2.142","article-title":"Polymorphisms of ATF6B are potentially associated with FEV1 decline by aspirin provocation in asthmatics","volume":"6","author":"Park","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2014.09.009_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/PDM.0b013e3182461d0d","article-title":"Potential association between ANXA4 polymorphisms and aspirin-exacerbated respiratory disease","volume":"21","author":"Park","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.jaip.2014.09.009_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/FPC.0b013e3283402155","article-title":"Effect of single nucleotide polymorphisms within the interleukin-4 promotor on aspirin intolerance in asthmatics and interleukin-4 promotor activity","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2014.09.009_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2014.09.009_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thx.51.1.64","article-title":"Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsysamples from aspirin-sensitive asthmatic subjects","volume":"51","author":"Nasser","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2014.09.009_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000351422","article-title":"The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma","volume":"162","author":"James","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jaci.2013.10.006","article-title":"Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma","volume":"133","author":"Schatz","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2010.11.015","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the NIH\/NHLBI Severe Asthma Research Program (SARP)","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.09.009_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.09.009_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1183\/09031936.00120810","article-title":"Identifying adult asthma phenotypes using a clustering approach","volume":"38","author":"Siroux","year":"2011","journal-title":"Eur Respir J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814004073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814004073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:07:29Z","timestamp":1761973649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219814004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213219814004073"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.09.009","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin or Other Nonsteroidal Inflammatory Agent Exacerbated Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}